Abstract
Studies have shown poor prognostic implications of anemia in patients with myocardial infarction (MI) and in patients undergoing percutaneous coronary intervention (PCI). The impact of blood transfusion in these populations remains controversial. The objective of this study was to examine the effect of transfusion on in‐hospital mortality in anemic patients undergoing PCI for MI.
Data from 67,051 PCIs (June 1, 1997 to January 31, 2004) were prospectively collected in a multicenter registry (Blue Cross Blue Shield of Michigan Cardiovascular Consortium). Of these, 4,623 patients who were classified as anemic according to the World Health Organization criteria underwent PCI within 7 days of presentation with acute MI. A propensity score for being transfused was estimated for each patient, and propensity matching and a prediction model for in‐hospital death were developed.
The average age was 67.8 years, 57.7% of patients were men, and 22.3% of patients received a transfusion during hospitalization. Transfused patients, compared to nontransfused patients, were more likely to be older, female, have lower preprocedure hemoglobin levels, more comorbidities, and a higher unadjusted in‐hospital mortality rate (14.52% vs. 3.01%, p < 0.0001). After adjustment for comorbidities and propensity for transfusion, blood transfusion was associated with a higher risk of in‐hospital mortality (adjusted odds ratio = 2.02, 95% confidence interval 1.47–2.79, p < 0.0001).
In anemic patients undergoing PCI for MI, transfusion was associated with an increased crude and adjusted rate of in‐hospital mortality. A randomized controlled trial is needed to determine the value of transfusion and the ideal transfusion criteria. Copyright © 2007 Wiley Periodicals, Inc.
Keywords: blood transfusion, myocardial infarction, percutaneous coronary intervention, mortality
Full Text
The Full Text of this article is available as a PDF (255.1 KB).
Supported by an unrestricted grant from Blue Cross Blue Shield of Michigan, Detroit, Michigan, USA.
References
- 1. McKechnie RS, Smith D, Montoye C, Kline‐Rogers E, O'Donnell MJ, et al., Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2): Prognostic implication of anemia on in‐hospital outcomes after percutaneous coronary intervention. Circulation 2004; 110(3): 271–277. [DOI] [PubMed] [Google Scholar]
- 2. Reinecke H, Trey T, Wellmann J, Heidrich J, Fobker M, et al.: Haemoglobin‐related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 2003; 24(23): 2142–2150. [DOI] [PubMed] [Google Scholar]
- 3. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, et al.: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340(6): 409–417. [DOI] [PubMed] [Google Scholar]
- 4. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, et al., ABC (Anemia and Blood Transfusion in Critical Care) Investigators: Anemia and blood transfusion in critically ill patients. JAMA 2002; 288(12): 1499–1507. [DOI] [PubMed] [Google Scholar]
- 5. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM: Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345(17): 1230–1236. [DOI] [PubMed] [Google Scholar]
- 6. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, et al.: Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292(13): 1555–1562. [DOI] [PubMed] [Google Scholar]
- 7. Kline‐Rogers E, Share D, Bondie D, Rogers B, Karavite D, et al., Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2): Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience. J Interv Cardiol 2002; 15(5): 387–392. [DOI] [PubMed] [Google Scholar]
- 8. Moscucci M, Share D, Kline‐Rogers E, O'Donnell M, Maxwell‐Eward A, et al., Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2): The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions. J Interv Cardiol 2002; 15(5): 381–386. [DOI] [PubMed] [Google Scholar]
- 9.The World Health Organization: Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5–37. [PubMed] [Google Scholar]
- 10. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS: Aspirin use and all‐cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis. JAMA 2001; 286(10): 1187–1194. [DOI] [PubMed] [Google Scholar]
- 11. Chan AW, Bhatt DL, Chew DP, Quinn MJ, Moliterno DJ, et al.: Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 2002; 105(6): 691–696. [DOI] [PubMed] [Google Scholar]
- 12. Englesbe MJ, Pelletier SJ, Diehl KM, Sung RS, Wahl WL, et al.: Transfusions in surgical patients. J Am Coll Surg 2005; 200(2): 249–254. [DOI] [PubMed] [Google Scholar]
- 13. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, et al.: Perioperative blood transfusion and postoperative mortality. JAMA 1998; 279(3): 199–205. [DOI] [PubMed] [Google Scholar]
- 14. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, et al.: Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005; 33(6): 1191–1198. [DOI] [PubMed] [Google Scholar]
- 15. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, et al.: Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002; 30(10): 2249–2254. [DOI] [PubMed] [Google Scholar]
- 16. Nagasawa H, Kurita K, Wada M, Kawanami T, Kato T: Blood transfusion‐induced irreversible brain damage. J Neurol 2005; 252(12): 1541–1542. [DOI] [PubMed] [Google Scholar]
- 17. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP: Transfusion medicine. First of two parts–blood transfusion. N Engl J Med 1999; 340(6): 438–447. [DOI] [PubMed] [Google Scholar]
- 18. Consensus conference: perioperative red blood cell transfusion. JAMA 1988; 260(18): 2700–2703. [PubMed] [Google Scholar]
- 19.American College of Physicians: Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116(5): 403–406. [DOI] [PubMed] [Google Scholar]
- 20.Expert Working Group: Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1997; 156: S1–S24. [DOI] [PubMed] [Google Scholar]
- 21. Moscucci M, Ricciardi M, Eagle KA, Kline E, Bates ER, et al.: Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions. Am J Cardiol 1998; 81(6): 702–707. [DOI] [PubMed] [Google Scholar]
- 22. Tinmouth A, MacDugall L, Fergusson D, Amin M, Graham ID, et al.: Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians' transfusion practices. Arch Intern Med 2005; 165(8): 845–852. [DOI] [PubMed] [Google Scholar]
- 23. Corwin H, Gettinger A, Pearl R, Fink MP, Levy MM, et al: EPO Critical Care Trials Group: Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002; 288(22) 2827–2835. [DOI] [PubMed] [Google Scholar]
- 24. Cothren C, Moore EE, Offner PJ, Haenel JB, Johnson JL: Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness. N Engl J Med 2002; 346(14): 1097–1098. [DOI] [PubMed] [Google Scholar]
- 25. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP: Transfusion medicine. Second of two parts–blood conservation. N Engl J Med 1999; 340(7): 525–533. [DOI] [PubMed] [Google Scholar]